273 related articles for article (PubMed ID: 32041553)
21. Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells.
Zhang HM; Sang XG; Wang YZ; Cui C; Zhang L; Ji WS
World J Gastroenterol; 2017 Apr; 23(15):2716-2722. PubMed ID: 28487608
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
Safa M; Kazemi A; Zaker F; Razmkhah F
J Recept Signal Transduct Res; 2011 Jun; 31(3):256-63. PubMed ID: 21619452
[TBL] [Abstract][Full Text] [Related]
25. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
26. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.
Horikawa I; Park KY; Isogaya K; Hiyoshi Y; Li H; Anami K; Robles AI; Mondal AM; Fujita K; Serrano M; Harris CC
Cell Death Differ; 2017 Jun; 24(6):1017-1028. PubMed ID: 28362428
[TBL] [Abstract][Full Text] [Related]
27. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
29. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target.
Han X; Garcia-Manero G; McDonnell TJ; Lozano G; Medeiros LJ; Xiao L; Rosner G; Nguyen M; Fernandez M; Valentin-Vega YA; Barboza J; Jones DM; Rassidakis GZ; Kantarjian HM; Bueso-Ramos CE
Mod Pathol; 2007 Jan; 20(1):54-62. PubMed ID: 17143258
[TBL] [Abstract][Full Text] [Related]
30. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
[TBL] [Abstract][Full Text] [Related]
32. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
33. Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript.
Marcel V; Perrier S; Aoubala M; Ageorges S; Groves MJ; Diot A; Fernandes K; Tauro S; Bourdon JC
FEBS Lett; 2010 Nov; 584(21):4463-8. PubMed ID: 20937277
[TBL] [Abstract][Full Text] [Related]
34. RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Steeghs EMP; Boer JM; Besselink NJM; Boeree A; van de Ven C; de Groot-Kruseman HA; de Haas V; Horstmann MA; Escherich G; Zwaan CM; Cuppen E; Koudijs MJ; Pieters R; den Boer ML
Leukemia; 2018 Apr; 32(4):931-940. PubMed ID: 28972594
[TBL] [Abstract][Full Text] [Related]
35. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells.
Melo Dos Santos N; de Oliveira GAP; Ramos Rocha M; Pedrote MM; Diniz da Silva Ferretti G; Pereira Rangel L; Morgado-Diaz JA; Silva JL; Rodrigues Pereira Gimba E
J Biol Chem; 2019 Jun; 294(24):9430-9439. PubMed ID: 31028175
[TBL] [Abstract][Full Text] [Related]
36. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
37. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.
Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW
J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53.
Graupner V; Schulze-Osthoff K; Essmann F; Jänicke RU
Cell Cycle; 2009 Apr; 8(8):1238-48. PubMed ID: 19305147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
